JAK1/2 inhibition with baricitinib in the treatment of autoinflammatory interferonopathiesGina A. Montealegre Sanchez, Jonathan Janes, Jason Dare et al.|Journal of Clinical Investigation|2018Cited by 519
Redefined clinical features and diagnostic criteria in autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophyElise M. N. Ferré, Michail S. Lionakis, Stacey Rose et al.|JCI Insight|2016Cited by 304
Treatment Strategies for Deficiency of Adenosine Deaminase 2Amanda K. Ombrello, Daniel L. Kastner, Jing Qin et al.|New England Journal of Medicine|2019Cited by 195
Pediatric CNS-isolated hemophagocytic lymphohistiocytosisLeslie Benson, Mark Gorman, Hojun Li et al.|Neurology Neuroimmunology & Neuroinflammation|2019Cited by 90